BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 2016;56:403-25. [PMID: 26514203 DOI: 10.1146/annurev-pharmtox-011613-135952] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Roy M, Horovitz A. Partitioning the Hill coefficient into contributions from ligand‐promoted conformational changes and subunit heterogeneity. Protein Science 2022;31. [DOI: 10.1002/pro.4298] [Reference Citation Analysis]
2 Sleno R, Hébert TE. The Dynamics of GPCR Oligomerization and Their Functional Consequences. Int Rev Cell Mol Biol 2018;338:141-71. [PMID: 29699691 DOI: 10.1016/bs.ircmb.2018.02.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
3 Ngamlertwong N, Tsuchiya H, Mochimaru Y, Azuma M, Kuchimaru T, Koshimizu TA. Agonist dependency of the second phase access of β-arrestin 2 to the heteromeric µ-V1b receptor. Sci Rep 2021;11:15813. [PMID: 34349143 DOI: 10.1038/s41598-021-94894-y] [Reference Citation Analysis]
4 Giakomidi D, Bird MF, McDonald J, Marzola E, Guerrini R, Chanoch S, Sabu N, Horley B, Calo G, Lambert DG. Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors. PLoS One 2021;16:e0250011. [PMID: 33891604 DOI: 10.1371/journal.pone.0250011] [Reference Citation Analysis]
5 Heneghan JF, Majmundar AJ, Rivera A, Wohlgemuth JG, Dlott JS, Snyder LM, Hildebrandt F, Alper SL. Activation of 2-oxoglutarate receptor 1 (OXGR1) by α-ketoglutarate (αKG) does not detectably stimulate Pendrin-mediated anion exchange in Xenopus oocytes. Physiol Rep 2022;10:e15362. [PMID: 35851763 DOI: 10.14814/phy2.15362] [Reference Citation Analysis]
6 Barker KE, Lecznar AJ, Schumacher JM, Morris JS, Gutstein HB. Subanalgesic morphine doses augment fentanyl analgesia by interacting with delta opioid receptors in male rats. J Neurosci Res 2021. [PMID: 34520585 DOI: 10.1002/jnr.24944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Matres JM, Hilscher J, Datta A, Armario-Nájera V, Baysal C, He W, Huang X, Zhu C, Valizadeh-Kamran R, Trijatmiko KR, Capell T, Christou P, Stoger E, Slamet-Loedin IH. Genome editing in cereal crops: an overview. Transgenic Res 2021;30:461-98. [PMID: 34263445 DOI: 10.1007/s11248-021-00259-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Prasad K, de Vries EFJ, Elsinga PH, Dierckx RAJO, van Waarde A. Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging. Int J Mol Sci 2021;22:1719. [PMID: 33572077 DOI: 10.3390/ijms22041719] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Botta J, Appelhans J, Mccormick PJ. Continuing challenges in targeting oligomeric GPCR-based drugs. Oligomerization in Health and Disease: From Enzymes to G Protein-Coupled Receptors. Elsevier; 2020. pp. 213-45. [DOI: 10.1016/bs.pmbts.2019.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Moreno E, Cavic M, Krivokuca A, Casadó V, Canela E. The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? Front Pharmacol 2019;10:339. [PMID: 31024307 DOI: 10.3389/fphar.2019.00339] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 16.7] [Reference Citation Analysis]
11 Gao X, Enten GA, DeSantis AJ, Volkman BF, Gaponenko V, Majetschak M. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α1-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays. Biochem Biophys Res Commun 2020;528:368-75. [PMID: 32085899 DOI: 10.1016/j.bbrc.2020.02.094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Navarro G, Cordomí A, Casadó-Anguera V, Moreno E, Cai NS, Cortés A, Canela EI, Dessauer CW, Casadó V, Pardo L, Lluís C, Ferré S. Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase. Nat Commun 2018;9:1242. [PMID: 29593213 DOI: 10.1038/s41467-018-03522-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 16.5] [Reference Citation Analysis]
13 Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. Int J Mol Sci 2016;17:E971. [PMID: 27331810 DOI: 10.3390/ijms17060971] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
14 Zhu J, Xiao Q, Yin L, Zhang F, Wen L, Suolang S, He K. Porcine circovirus-like virus P1 activates pancreatic secretion pathway by interacting with CHRM3 protein. Veterinary Microbiology 2022. [DOI: 10.1016/j.vetmic.2022.109495] [Reference Citation Analysis]
15 Zhou Y, Meng J, Xu C, Liu J. Multiple GPCR Functional Assays Based on Resonance Energy Transfer Sensors. Front Cell Dev Biol 2021;9:611443. [PMID: 34041234 DOI: 10.3389/fcell.2021.611443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zou S, Somvanshi RK, Kumar U. Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1. Neuroscience 2017;340:218-31. [PMID: 27984180 DOI: 10.1016/j.neuroscience.2016.10.056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
17 Puchert M, Obst J, Koch C, Zieger K, Engele J. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. Cytokine 2020;125:154809. [PMID: 31437604 DOI: 10.1016/j.cyto.2019.154809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
18 Tiwari V, He SQ, Huang Q, Liang L, Yang F, Chen Z, Tiwari V, Fujita W, Devi LA, Dong X, Guan Y, Raja SN. Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents. Pain 2020;161:842-55. [PMID: 31815916 DOI: 10.1097/j.pain.0000000000001768] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
19 Kleinau G, Müller A, Biebermann H. Oligomerization of GPCRs involved in endocrine regulation. J Mol Endocrinol 2016;57:R59-80. [PMID: 27151573 DOI: 10.1530/JME-16-0049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
20 Osorio-Barrios F, Navarro G, Campos J, Ugalde V, Prado C, Raïch I, Contreras F, López E, Espinoza A, Lladser A, Franco R, Pacheco R. The Heteromeric Complex Formed by Dopamine Receptor D5 and CCR9 Leads the Gut Homing of CD4+ T Cells Upon Inflammation. Cell Mol Gastroenterol Hepatol 2021;12:489-506. [PMID: 33864900 DOI: 10.1016/j.jcmgh.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gurevich VV, Gurevich EV. GPCRs and Signal Transducers: Interaction Stoichiometry. Trends Pharmacol Sci 2018;39:672-84. [PMID: 29739625 DOI: 10.1016/j.tips.2018.04.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
22 Kasai RS, Ito SV, Awane RM, Fujiwara TK, Kusumi A. The Class-A GPCR Dopamine D2 Receptor Forms Transient Dimers Stabilized by Agonists: Detection by Single-Molecule Tracking. Cell Biochem Biophys 2018;76:29-37. [PMID: 29116599 DOI: 10.1007/s12013-017-0829-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
23 Gomes I, Bobeck EN, Margolis EB, Gupta A, Sierra S, Fakira AK, Fujita W, Müller TD, Müller A, Tschöp MH, Kleinau G, Fricker LD, Devi LA. Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Sci Signal 2016;9:ra43. [PMID: 27117253 DOI: 10.1126/scisignal.aad0694] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
24 Porzionato A, Stocco E, Guidolin D, Agnati L, Macchi V, De Caro R. Receptor-Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis. Front Physiol 2018;9:697. [PMID: 29930516 DOI: 10.3389/fphys.2018.00697] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Mores KL, Cassell RJ, van Rijn RM. Arrestin recruitment and signaling by G protein-coupled receptor heteromers. Neuropharmacology 2019;152:15-21. [PMID: 30419245 DOI: 10.1016/j.neuropharm.2018.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
26 Ayoub MA. Resonance Energy Transfer-Based Approaches to Study GPCRs. Methods Cell Biol 2016;132:255-92. [PMID: 26928548 DOI: 10.1016/bs.mcb.2015.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
27 Park SH, Lee JH. Dynamic G Protein-Coupled Receptor Signaling Probed by Solution NMR Spectroscopy. Biochemistry 2020;59:1065-80. [PMID: 32092261 DOI: 10.1021/acs.biochem.0c00032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 Casadó-Anguera V, Moreno E, Mallol J, Ferré S, Canela EI, Cortés A, Casadó V. Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model. Pharmacol Res 2019;139:337-47. [PMID: 30472462 DOI: 10.1016/j.phrs.2018.11.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
29 Wang D, Wang Y, Shan M, Chen J, Wang H, Sun B, Jin C, Li X, Yin Y, Song C, Xiao C, Li J, Wang T, Cai X. Apelin receptor homodimer inhibits apoptosis in vascular dementia. Exp Cell Res 2021;407:112739. [PMID: 34343559 DOI: 10.1016/j.yexcr.2021.112739] [Reference Citation Analysis]
30 Casadó-anguera V, Cortés A, Casadó V, Moreno E. Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs. Expert Opinion on Drug Discovery 2019;14:1297-312. [DOI: 10.1080/17460441.2019.1664469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Machelska H, Celik MÖ. Advances in Achieving Opioid Analgesia Without Side Effects. Front Pharmacol 2018;9:1388. [PMID: 30555325 DOI: 10.3389/fphar.2018.01388] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
32 Fricker LD, Devi LA. Orphan neuropeptides and receptors: Novel therapeutic targets. Pharmacol Ther 2018;185:26-33. [PMID: 29174650 DOI: 10.1016/j.pharmthera.2017.11.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
33 Poulie CBM, Liu N, Jensen AA, Bunch L. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex. J Med Chem 2020;63:9928-49. [PMID: 32815361 DOI: 10.1021/acs.jmedchem.0c01058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Shchepinova MM, Hanyaloglu AC, Frost GS, Tate EW. Chemical biology of noncanonical G protein-coupled receptor signaling: Toward advanced therapeutics. Curr Opin Chem Biol 2020;56:98-110. [PMID: 32446179 DOI: 10.1016/j.cbpa.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Schneider EH, Seifert R. Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System. Handb Exp Pharmacol 2017;241:63-118. [PMID: 28233175 DOI: 10.1007/164_2016_124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Blasco-Benito S, Moreno E, Seijo-Vila M, Tundidor I, Andradas C, Caffarel MM, Caro-Villalobos M, Urigüen L, Diez-Alarcia R, Moreno-Bueno G, Hernández L, Manso L, Homar-Ruano P, McCormick PJ, Bibic L, Bernadó-Morales C, Arribas J, Canals M, Casadó V, Canela EI, Guzmán M, Pérez-Gómez E, Sánchez C. Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. Proc Natl Acad Sci U S A 2019;116:3863-72. [PMID: 30733293 DOI: 10.1073/pnas.1815034116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
37 Gomes I, Sierra S, Devi LA. Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay. Curr Protoc Pharmacol 2016;75:2.16.1-2.16.31. [PMID: 27960030 DOI: 10.1002/cpph.15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
38 Keri D, Barth P. Reprogramming G protein coupled receptor structure and function. Curr Opin Struct Biol 2018;51:187-94. [PMID: 30055347 DOI: 10.1016/j.sbi.2018.07.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
39 El Khamlichi C, Cobret L, Arrang JM, Morisset-Lopez S. BRET Analysis of GPCR Dimers in Neurons and Non-Neuronal Cells: Evidence for Inactive, Agonist, and Constitutive Conformations. Int J Mol Sci 2021;22:10638. [PMID: 34638980 DOI: 10.3390/ijms221910638] [Reference Citation Analysis]
40 De Oliveira PA, Moreno E, Casajuana-Martin N, Casadó-Anguera V, Cai NS, Camacho-Hernandez GA, Zhu H, Bonifazi A, Hall MD, Weinshenker D, Newman AH, Logothetis DE, Casadó V, Plant LD, Pardo L, Ferré S. Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer. Pharmacol Res 2022;182:106322. [PMID: 35750299 DOI: 10.1016/j.phrs.2022.106322] [Reference Citation Analysis]
41 Ayoub MA, Yvinec R, Crépieux P, Poupon A. Computational modeling approaches in gonadotropin signaling. Theriogenology 2016;86:22-31. [DOI: 10.1016/j.theriogenology.2016.04.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
42 Levashova AI, Myagkova MA. Mechanism of action of anti-opioid peptides at pain syndrome. Russ Chem Bull 2018;67:624-35. [DOI: 10.1007/s11172-018-2116-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Misganaw D. Heteromerization of dopaminergic receptors in the brain: Pharmacological implications. Pharmacol Res 2021;170:105600. [PMID: 33836279 DOI: 10.1016/j.phrs.2021.105600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Sierra S, Gupta A, Gomes I, Fowkes M, Ram A, Bobeck EN, Devi LA. Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain. ACS Pharmacol Transl Sci 2019;2:219-29. [PMID: 31565698 DOI: 10.1021/acsptsci.9b00008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
45 Cahill CM, Ong E. Evidence and Function Relevance of Native DOR–MOR Heteromers. In: Jutkiewicz EM, editor. Delta Opioid Receptor Pharmacology and Therapeutic Applications. Cham: Springer International Publishing; 2018. pp. 115-27. [DOI: 10.1007/164_2018_112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
46 Pourrahimi AM, Abbasnejad M, Esmaeili-mahani S, Kooshki R, Raoof M. Intra-periaqueductal gray matter administration of orexin-A exaggerates pulpitis-induced anxiogenic responses and c-fos expression mainly through the interaction with orexin 1 and cannabinoid 1 receptors in rats. Neuropeptides 2019;73:25-33. [DOI: 10.1016/j.npep.2018.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
47 Bartuzi D, Kaczor AA, Matosiuk D. Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors. Molecules 2017;22:E1188. [PMID: 28714871 DOI: 10.3390/molecules22071188] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
48 Khan AB, Carpenter B, Santos E Sousa P, Pospori C, Khorshed R, Griffin J, Velica P, Zech M, Ghorashian S, Forrest C, Thomas S, Gonzalez Anton S, Ahmadi M, Holler A, Flutter B, Ramirez-Ortiz Z, Means TK, Bennett CL, Stauss H, Morris E, Lo Celso C, Chakraverty R. Redirection to the bone marrow improves T cell persistence and antitumor functions. J Clin Invest. 2018;128:2010-2024. [PMID: 29485974 DOI: 10.1172/jci97454] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
49 Wan L, Xu F, Liu C, Ji B, Zhang R, Wang P, Wu F, Pan Y, Yang C, Wang C, Chen J. Transmembrane peptide 4 and 5 of APJ are essential for its heterodimerization with OX1R. Biochemical and Biophysical Research Communications 2020;521:408-13. [DOI: 10.1016/j.bbrc.2019.10.146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Petit-Pedrol M, Groc L. Regulation of membrane NMDA receptors by dynamics and protein interactions. J Cell Biol 2021;220:e202006101. [PMID: 33337489 DOI: 10.1083/jcb.202006101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Babu FS, Liang X, Enten GA, DeSantis AJ, Volkman BF, Gao X, Majetschak M. Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage. Sci Rep 2020;10:11359. [PMID: 32647374 DOI: 10.1038/s41598-020-68425-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Wei F, Zhao L, Jing Y. Hemoglobin-derived peptides and mood regulation. Peptides 2020;127:170268. [PMID: 32070683 DOI: 10.1016/j.peptides.2020.170268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
53 Cervetto C, Venturini A, Guidolin D, Maura G, Passalacqua M, Tacchetti C, Cortelli P, Genedani S, Candiani S, Ramoino P, Pelassa S, Marcoli M, Agnati LF. Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes. J Mol Neurosci 2018;65:456-66. [PMID: 30030763 DOI: 10.1007/s12031-018-1120-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
54 Xue Q, Bai B, Ji B, Chen X, Wang C, Wang P, Yang C, Zhang R, Jiang Y, Pan Y, Cheng B, Chen J. Ghrelin Through GHSR1a and OX1R Heterodimers Reveals a Gαs-cAMP-cAMP Response Element Binding Protein Signaling Pathway in Vitro. Front Mol Neurosci 2018;11:245. [PMID: 30065627 DOI: 10.3389/fnmol.2018.00245] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
55 Albee LJ, Eby JM, Tripathi A, LaPorte HM, Gao X, Volkman BF, Gaponenko V, Majetschak M. α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells. J Am Heart Assoc 2017;6:e006575. [PMID: 28862946 DOI: 10.1161/JAHA.117.006575] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
56 Müller A, Berkmann JC, Scheerer P, Biebermann H, Kleinau G. Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83. PLoS One 2016;11:e0168260. [PMID: 27936173 DOI: 10.1371/journal.pone.0168260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
57 Frank T, Reichel A, Larsen O, Stilp AC, Rosenkilde MM, Stamminger T, Ozawa T, Tschammer N. Attenuation of chemokine receptor function and surface expression as an immunomodulatory strategy employed by human cytomegalovirus is linked to vGPCR US28. Cell Commun Signal 2016;14:31. [PMID: 27955674 DOI: 10.1186/s12964-016-0154-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
58 Catar RA, Wischnewski O, Chen L, Heidecke H, Rutz C, Schülein R, Dragun D, Philippe A, Kusch A. Non-HLA antibodies targeting angiotensin II type 1 receptors and endothelin-1 type A receptors impair endothelial repair via a β2-arrestin link to the mTOR pathway. Kidney Int 2021:S0085-2538(21)01026-7. [PMID: 34757123 DOI: 10.1016/j.kint.2021.09.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
59 Kukkonen JP. Allosteric interactions via the orthosteric ligand binding sites in a constitutive G-protein-coupled receptor homodimer. Pharmacol Res 2021;166:105116. [PMID: 32783977 DOI: 10.1016/j.phrs.2020.105116] [Reference Citation Analysis]
60 Pelassa S, Guidolin D, Venturini A, Averna M, Frumento G, Campanini L, Bernardi R, Cortelli P, Buonaura GC, Maura G, Agnati LF, Cervetto C, Marcoli M. A2A-D2 Heteromers on Striatal Astrocytes: Biochemical and Biophysical Evidence. Int J Mol Sci 2019;20:E2457. [PMID: 31109007 DOI: 10.3390/ijms20102457] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
61 Jacobs BA, Pando MM, Jennings EM, Jamshidi RJ, Zamora JC, Chavera TS, Clarke WP, Berg KA. Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons. Neuropharmacology 2019;151:208-18. [PMID: 30776373 DOI: 10.1016/j.neuropharm.2019.02.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Johnstone EKM, Pfleger KDG. Profiling novel pharmacology of receptor complexes using Receptor-HIT. Biochem Soc Trans 2021;49:1555-65. [PMID: 34436548 DOI: 10.1042/BST20201110] [Reference Citation Analysis]
63 Hill SJ, Watson SP. Fluorescence Approaches Unravel Spatial and Temporal Aspects of GPCR Organisation, Location, and Intracellular Signalling. Trends Pharmacol Sci 2018;39:91-2. [PMID: 29276072 DOI: 10.1016/j.tips.2017.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
64 Bagher AM, Laprairie RB, Toguri JT, Kelly MEM, Denovan-Wright EM. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers. Eur J Pharmacol 2017;813:66-83. [PMID: 28734930 DOI: 10.1016/j.ejphar.2017.07.034] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
65 Wootten D, Christopoulos A, Marti-solano M, Babu MM, Sexton PM. Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat Rev Mol Cell Biol 2018;19:638-53. [DOI: 10.1038/s41580-018-0049-3] [Cited by in Crossref: 200] [Cited by in F6Publishing: 183] [Article Influence: 50.0] [Reference Citation Analysis]
66 Sposini S, Hanyaloglu AC. Spatial encryption of G protein-coupled receptor signaling in endosomes; Mechanisms and applications. Biochemical Pharmacology 2017;143:1-9. [DOI: 10.1016/j.bcp.2017.04.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
67 Albee LJ, LaPorte HM, Gao X, Eby JM, Cheng YH, Nevins AM, Volkman BF, Gaponenko V, Majetschak M. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. Open Biol 2018;8:170207. [PMID: 29386406 DOI: 10.1098/rsob.170207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
68 Szymańska K, Kałafut J, Przybyszewska A, Paziewska B, Adamczuk G, Kiełbus M, Rivero-Müller A. FSHR Trans-Activation and Oligomerization. Front Endocrinol (Lausanne) 2018;9:760. [PMID: 30619090 DOI: 10.3389/fendo.2018.00760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
69 Gerbier R, Ndiaye-Lobry D, Martinez de Morentin PB, Cecon E, Heisler LK, Delagrange P, Gbahou F, Jockers R. Pharmacological evidence for transactivation within melatonin MT2 and serotonin 5-HT2C receptor heteromers in mouse brain. FASEB J 2021;35:e21161. [PMID: 33156577 DOI: 10.1096/fj.202000305R] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Oliveira PA, Dalton JAR, López-Cano M, Ricarte A, Morató X, Matheus FC, Cunha AS, Müller CE, Takahashi RN, Fernández-Dueñas V, Giraldo J, Prediger RD, Ciruela F. Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia. Sci Rep 2017;7:1857. [PMID: 28500295 DOI: 10.1038/s41598-017-02037-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
71 Majumder A, Kwon S, Straub JE. On Computing Equilibrium Binding Constants for Protein-Protein Association in Membranes. J Chem Theory Comput 2022. [PMID: 35580264 DOI: 10.1021/acs.jctc.2c00106] [Reference Citation Analysis]
72 Pulido D, Casadó-Anguera V, Gómez-Autet M, Llopart N, Moreno E, Casajuana-Martin N, Ferré S, Pardo L, Casadó V, Royo M. Heterobivalent Ligand for the Adenosine A2A-Dopamine D2 Receptor Heteromer. J Med Chem 2022;65:616-32. [PMID: 34982555 DOI: 10.1021/acs.jmedchem.1c01763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Fujita W. The Possible Role of MOPr-DOPr Heteromers and Its Regulatory Protein RTP4 at Sensory Neurons in Relation to Pain Perception. Front Cell Neurosci 2020;14:609362. [PMID: 33304244 DOI: 10.3389/fncel.2020.609362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Bourque K, Jones-tabah J, Devost D, Clarke PB, Hébert TE. Exploring functional consequences of GPCR oligomerization requires a different lens. Oligomerization in Health and Disease: From Enzymes to G Protein-Coupled Receptors. Elsevier; 2020. pp. 181-211. [DOI: 10.1016/bs.pmbts.2019.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
75 Wu Q, Regan M, Furukawa H, Jackson D. Role of heterotrimeric Gα proteins in maize development and enhancement of agronomic traits. PLoS Genet 2018;14:e1007374. [PMID: 29708966 DOI: 10.1371/journal.pgen.1007374] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
76 Taura J, Valle-León M, Sahlholm K, Watanabe M, Van Craenenbroeck K, Fernández-Dueñas V, Ferré S, Ciruela F. Behavioral control by striatal adenosine A2A -dopamine D2 receptor heteromers. Genes Brain Behav 2018;17:e12432. [PMID: 29053217 DOI: 10.1111/gbb.12432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
77 Jonas K, Hanyaloglu A. Impact of G protein-coupled receptor heteromers in endocrine systems. Molecular and Cellular Endocrinology 2017;449:21-7. [DOI: 10.1016/j.mce.2017.01.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
78 Majewski MW, Gandhi DM, Rosas R Jr, Kodali R, Arnold LA, Dockendorff C. Design and Evaluation of Heterobivalent PAR1-PAR2 Ligands as Antagonists of Calcium Mobilization. ACS Med Chem Lett 2019;10:121-6. [PMID: 30655958 DOI: 10.1021/acsmedchemlett.8b00538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
79 Wang L, Yuan Y, Chen X, Chen J, Guo Y, Li M, Li C, Pu X. Probing the cooperative mechanism of the μ–δ opioid receptor heterodimer by multiscale simulation. Phys Chem Chem Phys 2018;20:29969-82. [DOI: 10.1039/c8cp06652c] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
80 Kenakin T, Barker EL. Biased Receptor Signaling in Drug Discovery. Pharmacol Rev 2019;71:267-315. [DOI: 10.1124/pr.118.016790] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 30.3] [Reference Citation Analysis]
81 Ferré S, Ciruela F, Casadó V, Pardo L. Oligomerization of G protein-coupled receptors: Still doubted? Oligomerization in Health and Disease: From Enzymes to G Protein-Coupled Receptors. Elsevier; 2020. pp. 297-321. [DOI: 10.1016/bs.pmbts.2019.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
82 Degrandmaison J, Grisé O, Parent JL, Gendron L. Differential barcoding of opioid receptors trafficking. J Neurosci Res 2021. [PMID: 34559903 DOI: 10.1002/jnr.24949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Lu E, Cyster JG. G-protein coupled receptors and ligands that organize humoral immune responses. Immunol Rev 2019;289:158-72. [PMID: 30977196 DOI: 10.1111/imr.12743] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
84 Gomes JI, Farinha-Ferreira M, Rei N, Gonçalves-Ribeiro J, Ribeiro JA, Sebastião AM, Vaz SH. Of adenosine and the blues: The adenosinergic system in the pathophysiology and treatment of major depressive disorder. Pharmacol Res 2021;163:105363. [PMID: 33285234 DOI: 10.1016/j.phrs.2020.105363] [Reference Citation Analysis]
85 Al Zamel I, Palakkott A, Ayoub MA. Synergistic activation of thrombin and angiotensin II receptors revealed by bioluminescence resonance energy transfer. FEBS Lett 2021;595:2628-37. [PMID: 34455594 DOI: 10.1002/1873-3468.14187] [Reference Citation Analysis]
86 Cai X, Bai B, Zhang R, Wang C, Chen J. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling. Sci Rep 2017;7:40335. [PMID: 28091541 DOI: 10.1038/srep40335] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
87 Bansal R, Engle SE, Antonellis PJ, Whitehouse LS, Baucum AJ 2nd, Cummins TR, Reiter JF, Berbari NF. Hedgehog Pathway Activation Alters Ciliary Signaling in Primary Hypothalamic Cultures. Front Cell Neurosci 2019;13:266. [PMID: 31249512 DOI: 10.3389/fncel.2019.00266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
88 sun H, Zhang C, Ma Y, Du M, Chen T. Controlling and online measurement of automatic dual-channel E-FRET microscope. Biomedical Signal Processing and Control 2019;53:101585. [DOI: 10.1016/j.bspc.2019.101585] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Casarini L, Lazzaretti C, Paradiso E, Limoncella S, Riccetti L, Sperduti S, Melli B, Marcozzi S, Anzivino C, Sayers NS, Czapinski J, Brigante G, Potì F, La Marca A, De Pascali F, Reiter E, Falbo A, Daolio J, Villani MT, Lispi M, Orlando G, Klinger FG, Fanelli F, Rivero-Müller A, Hanyaloglu AC, Simoni M. Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival. iScience 2020;23:101812. [PMID: 33299978 DOI: 10.1016/j.isci.2020.101812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
90 Ozdeslik RN, Olinski LE, Trieu MM, Oprian DD, Oancea E. Human nonvisual opsin 3 regulates pigmentation of epidermal melanocytes through functional interaction with melanocortin 1 receptor. Proc Natl Acad Sci U S A 2019;116:11508-17. [PMID: 31097585 DOI: 10.1073/pnas.1902825116] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
91 Ferré S, Ciruela F, Dessauer CW, González-Maeso J, Hébert TE, Jockers R, Logothetis DE, Pardo L. G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs). Pharmacol Ther 2021;:107977. [PMID: 34480967 DOI: 10.1016/j.pharmthera.2021.107977] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 de Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect 2020;8:e00682. [PMID: 33169541 DOI: 10.1002/prp2.682] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
93 Gimpl G. Interaction of G protein coupled receptors and cholesterol. Chem Phys Lipids 2016;199:61-73. [PMID: 27108066 DOI: 10.1016/j.chemphyslip.2016.04.006] [Cited by in Crossref: 116] [Cited by in F6Publishing: 100] [Article Influence: 19.3] [Reference Citation Analysis]
94 Bontempi L, Savoia P, Bono F, Fiorentini C, Missale C. Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity. Eur Neuropsychopharmacol 2017;27:313-24. [PMID: 28187919 DOI: 10.1016/j.euroneuro.2017.01.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
95 Fillion D, Devost D, Hébert TE. Measuring Recruitment of β-Arrestin to G Protein-Coupled Heterodimers Using Bioluminescence Resonance Energy Transfer. Methods Mol Biol 2019;1957:83-91. [PMID: 30919348 DOI: 10.1007/978-1-4939-9158-7_5] [Reference Citation Analysis]
96 Mak SOK, Zhang L, Chow BKC. In vivo actions of SCTR/AT1aR heteromer in controlling Vp expression and release via cFos/cAMP/CREB pathway in magnocellular neurons of PVN. FASEB j 2019;33:5389-98. [DOI: 10.1096/fj.201801732rr] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
97 DelaCuesta-Barrutia J, Peñagarikano O, Erdozain AM. G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism. Front Cell Neurosci 2020;14:588662. [PMID: 33192330 DOI: 10.3389/fncel.2020.588662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Marceau F, Bawolak MT, Fortin JP, Morissette G, Roy C, Bachelard H, Gera L, Charest-Morin X. Bifunctional ligands of the bradykinin B2 and B1 receptors: An exercise in peptide hormone plasticity. Peptides. 2018;105:37-50. [PMID: 29802875 DOI: 10.1016/j.peptides.2018.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
99 Newman AH, Battiti FO, Bonifazi A. 2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts. J Med Chem 2020;63:1779-97. [PMID: 31499001 DOI: 10.1021/acs.jmedchem.9b01105] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
100 Sierra S, Lippold KM, Stevens DL, Poklis JL, Dewey WL, González-Maeso J. Adjunctive effect of the serotonin 5-HT2C receptor agonist lorcaserin on opioid-induced antinociception in mice. Neuropharmacology 2020;167:107949. [PMID: 31987863 DOI: 10.1016/j.neuropharm.2020.107949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
101 Wouters E, Vasudevan L, Crans RAJ, Saini DK, Stove CP. Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art. Int J Mol Sci 2019;20:E2958. [PMID: 31213021 DOI: 10.3390/ijms20122958] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
102 Cruz SL, Sánchez-Miranda E, Castillo-Arellano JI, Cervantes-Villagrana RD, Ibarra-Sánchez A, González-Espinosa C. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers. Int Immunopharmacol 2018;64:298-307. [PMID: 30243065 DOI: 10.1016/j.intimp.2018.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
103 Cai NS, Quiroz C, Bonaventura J, Bonifazi A, Cole TO, Purks J, Billing AS, Massey E, Wagner M, Wish ED, Guitart X, Rea W, Lam S, Moreno E, Casadó-Anguera V, Greenblatt AD, Jacobson AE, Rice KC, Casadó V, Newman AH, Winkelman JW, Michaelides M, Weintraub E, Volkow ND, Belcher AM, Ferré S. Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids. J Clin Invest 2019;129:2730-44. [PMID: 30913037 DOI: 10.1172/JCI126912] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
104 Zhang J, Simpson PC, Jensen BC. Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases. Am J Physiol Heart Circ Physiol 2021;320:H725-33. [PMID: 33275531 DOI: 10.1152/ajpheart.00621.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Jorand R, Biswas S, Wakefield DL, Tobin SJ, Golfetto O, Hilton K, Ko M, Ramos JW, Small AR, Chu P, Singh G, Jovanovic-Talisman T. Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer. Mol Biol Cell 2016;27:3659-72. [PMID: 27682590 DOI: 10.1091/mbc.E16-06-0427] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
106 Lobas MA, Tao R, Nagai J, Kronschläger MT, Borden PM, Marvin JS, Looger LL, Khakh BS. A genetically encoded single-wavelength sensor for imaging cytosolic and cell surface ATP. Nat Commun 2019;10:711. [PMID: 30755613 DOI: 10.1038/s41467-019-08441-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 24.3] [Reference Citation Analysis]
107 Liu J, Zhang Z, Moreno-Delgado D, Dalton JA, Rovira X, Trapero A, Goudet C, Llebaria A, Giraldo J, Yuan Q, Rondard P, Huang S, Liu J, Pin JP. Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer. Elife 2017;6:e26985. [PMID: 28829739 DOI: 10.7554/eLife.26985] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
108 Gewehr MCF, Silverio R, Rosa-Neto JC, Lira FS, Reckziegel P, Ferro ES. Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies. Molecules 2020;25:E1093. [PMID: 32121443 DOI: 10.3390/molecules25051093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Bono F, Mutti V, Devoto P, Bolognin S, Schwamborn JC, Missale C, Fiorentini C. Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation. Neurobiol Aging 2021;99:65-78. [PMID: 33422895 DOI: 10.1016/j.neurobiolaging.2020.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
110 Pin JP, Kniazeff J, Prézeau L, Liu JF, Rondard P. GPCR interaction as a possible way for allosteric control between receptors. Mol Cell Endocrinol 2019;486:89-95. [PMID: 30849406 DOI: 10.1016/j.mce.2019.02.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
111 Cuitavi J, Hipólito L, Canals M. The Life Cycle of the Mu-Opioid Receptor. Trends Biochem Sci 2021;46:315-28. [PMID: 33127216 DOI: 10.1016/j.tibs.2020.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
112 López-Ramírez G, Sánchez-Zavaleta R, Ávalos-Fuentes A, José Sierra J, Paz-Bermúdez F, Leyva-Gómez G, Segovia Vila J, Cortés H, Florán B. D2 autoreceptor switches CB2 receptor effects on [3 H]-dopamine release in the striatum. Synapse 2020;74:e22139. [PMID: 31610050 DOI: 10.1002/syn.22139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
113 Cervetto C, Venturini A, Passalacqua M, Guidolin D, Genedani S, Fuxe K, Borroto-Esquela DO, Cortelli P, Woods A, Maura G, Marcoli M, Agnati LF. A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes. J Neurochem 2017;140:268-79. [PMID: 27896809 DOI: 10.1111/jnc.13885] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
114 Gao X, Cheng YH, Enten GA, DeSantis AJ, Gaponenko V, Majetschak M. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4. J Biol Chem 2020;295:14893-905. [PMID: 32839271 DOI: 10.1074/jbc.RA120.015355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
115 Paek J, Kalocsay M, Staus DP, Wingler L, Pascolutti R, Paulo JA, Gygi SP, Kruse AC. Multidimensional Tracking of GPCR Signaling via Peroxidase-Catalyzed Proximity Labeling. Cell 2017;169:338-349.e11. [PMID: 28388415 DOI: 10.1016/j.cell.2017.03.028] [Cited by in Crossref: 126] [Cited by in F6Publishing: 105] [Article Influence: 25.2] [Reference Citation Analysis]
116 Mutti V, Bono F, Tomasoni Z, Bontempi L, Guglielmi A, Bolognin S, Schwamborn JC, Missale C, Fiorentini C. Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway. Mol Neurobiol 2022. [PMID: 35044626 DOI: 10.1007/s12035-022-02748-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Gao X, Enten GA, DeSantis AJ, Majetschak M. Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers. FEBS Lett 2021;595:1863-75. [PMID: 34032285 DOI: 10.1002/1873-3468.14135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Xue L, Sun Q, Zhao H, Rovira X, Gai S, He Q, Pin JP, Liu J, Rondard P. Rearrangement of the transmembrane domain interfaces associated with the activation of a GPCR hetero-oligomer. Nat Commun 2019;10:2765. [PMID: 31235691 DOI: 10.1038/s41467-019-10834-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
119 Rukavina Mikusic NL, Silva MG, Pineda AM, Gironacci MM. Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function? Front Pharmacol 2020;11:1179. [PMID: 32848782 DOI: 10.3389/fphar.2020.01179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
120 Manchia M, Comai S, Pinna M, Pinna F, Fanos V, Denovan-Wright E, Carpiniello B. Biomarkers in aggression. Adv Clin Chem 2019;93:169-237. [PMID: 31655730 DOI: 10.1016/bs.acc.2019.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
121 Ehrlich AT, Kieffer BL, Darcq E. Current strategies toward safer mu opioid receptor drugs for pain management. Expert Opin Ther Targets 2019;23:315-26. [PMID: 30802415 DOI: 10.1080/14728222.2019.1586882] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
122 Jacobs BA, Pando MM, Jennings E, Chavera TA, Clarke WP, Berg KA. Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy. Mol Pharmacol 2018;93:376-86. [PMID: 29436492 DOI: 10.1124/mol.117.109975] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
123 Nagano K, Kwon C, Ishida J, Hashimoto T, Kim J, Kishikawa N, Murao M, Kimura K, Kasuya Y, Kimura S, Chen Y, Tsuchimochi H, Shirai M, Pearson JT, Fukamizu A. Cooperative action of APJ and α1A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction. The Journal of Biochemistry 2019;166:383-92. [DOI: 10.1093/jb/mvz071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
124 Javanainen M, Martinez-Seara H, Vattulainen I. Excessive aggregation of membrane proteins in the Martini model. PLoS One 2017;12:e0187936. [PMID: 29131844 DOI: 10.1371/journal.pone.0187936] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 17.0] [Reference Citation Analysis]
125 Albee LJ, Gao X, Majetschak M. Plasticity of seven-transmembrane-helix receptor heteromers in human vascular smooth muscle cells. PLoS One 2021;16:e0253821. [PMID: 34166476 DOI: 10.1371/journal.pone.0253821] [Reference Citation Analysis]
126 Chakraborty S, Uprety R, Daibani AE, Rouzic VL, Hunkele A, Appourchaux K, Eans SO, Nuthikattu N, Jilakara R, Thammavong L, Pasternak GW, Pan YX, McLaughlin JP, Che T, Majumdar S. Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom. ACS Chem Neurosci 2021;12:2661-78. [PMID: 34213886 DOI: 10.1021/acschemneuro.1c00149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
127 Ayoub MA. Angiotensin II type 1 receptor heterodimers in the kidney. Current Opinion in Endocrine and Metabolic Research 2021;16:96-101. [DOI: 10.1016/j.coemr.2020.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Gendron L, Cahill CM, von Zastrow M, Schiller PW, Pineyro G. Molecular Pharmacology of δ-Opioid Receptors. Pharmacol Rev 2016;68:631-700. [PMID: 27343248 DOI: 10.1124/pr.114.008979] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
129 Dong X, Zeng W, Zhang W, Lan Y, Wang Y, Feng J, Gu L, Lu H. Opsin 3 Regulates Melanogenesis in Human Congenital Melanocytic Nevus Cells via Functional Interaction with BRAFV600E. Journal of Investigative Dermatology 2022. [DOI: 10.1016/j.jid.2022.04.022] [Reference Citation Analysis]
130 Lewis MH, Primiani CT, Muehlmann AM. Targeting Dopamine D2, Adenosine A2A, and Glutamate mGlu5 Receptors to Reduce Repetitive Behaviors in Deer Mice. J Pharmacol Exp Ther 2019;369:88-97. [PMID: 30745415 DOI: 10.1124/jpet.118.256081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
131 Degrandmaison J, Abdallah K, Blais V, Génier S, Lalumière MP, Bergeron F, Cahill CM, Boulter J, Lavoie CL, Parent JL, Gendron L. In vivo mapping of a GPCR interactome using knockin mice. Proc Natl Acad Sci U S A 2020;117:13105-16. [PMID: 32457152 DOI: 10.1073/pnas.1917906117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
132 Ferré S. Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders. Curr Treat Options Psychiatry 2017;4:167-83. [PMID: 28580231 DOI: 10.1007/s40501-017-0109-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
133 Matera C, Bono F, Pelucchi S, Collo G, Bontempi L, Gotti C, Zoli M, De Amici M, Missale C, Fiorentini C, Dallanoce C. The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons. Biochem Pharmacol 2019;163:154-68. [PMID: 30772268 DOI: 10.1016/j.bcp.2019.02.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
134 Toneatti R, Shin JM, Shah UH, Mayer CR, Saunders JM, Fribourg M, Arsenovic PT, Janssen WG, Sealfon SC, López-Giménez JF, Benson DL, Conway DE, González-Maeso J. Interclass GPCR heteromerization affects localization and trafficking. Sci Signal 2020;13:eaaw3122. [PMID: 33082287 DOI: 10.1126/scisignal.aaw3122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
135 Faouzi A, Uprety R, Gomes I, Massaly N, Keresztes AI, Le Rouzic V, Gupta A, Zhang T, Yoon HJ, Ansonoff M, Allaoa A, Pan YX, Pintar J, Morón JA, Streicher JM, Devi LA, Majumdar S. Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template. J Med Chem 2020;63:13618-37. [PMID: 33170687 DOI: 10.1021/acs.jmedchem.0c00901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
136 Casarini L, Santi D, Simoni M, Potì F. 'Spare' Luteinizing Hormone Receptors: Facts and Fiction. Trends Endocrinol Metab 2018;29:208-17. [PMID: 29429918 DOI: 10.1016/j.tem.2018.01.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
137 Koshimizu T, Honda K, Nagaoka-uozumi S, Ichimura A, Kimura I, Nakaya M, Sakai N, Shibata K, Ushijima K, Fujimura A, Hirasawa A, Kurose H, Tsujimoto G, Tanoue A, Takano Y. Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance. Nat Neurosci 2018;21:820-33. [DOI: 10.1038/s41593-018-0144-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
138 Zhang L, Zhang JT, Hang L, Liu T. Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective. Front Pharmacol 2020;11:1078. [PMID: 32760281 DOI: 10.3389/fphar.2020.01078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
139 Sachdev S, Cabalteja CC, Cheloha RW. Strategies for targeting cell surface proteins using multivalent conjugates and chemical biology. Methods Cell Biol 2021;166:205-22. [PMID: 34752333 DOI: 10.1016/bs.mcb.2021.06.004] [Reference Citation Analysis]
140 Łukasiewicz S. Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D2-Serotonin 5-HT1A Heteromers. Polymers (Basel) 2021;13:1000. [PMID: 33805130 DOI: 10.3390/polym13071000] [Reference Citation Analysis]
141 Scheggi S, Ferrari A, Pelliccia T, Devoto P, De Montis MG, Gambarana C. Fasting biases μ-opioid receptors toward β-arrestin2-dependent signaling in the accumbens shell. Neuroscience 2017;352:19-29. [PMID: 28391016 DOI: 10.1016/j.neuroscience.2017.03.056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
142 Kang W, Liu S, Xu J, Abrimian A, Malik AF, Chien R, Adaralegbe A, Amponsah A, Cartegni L, Pintar J, Pan YX. Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models. Int J Mol Sci 2022;23:3010. [PMID: 35328429 DOI: 10.3390/ijms23063010] [Reference Citation Analysis]
143 Sanna MD, Borgonetti V, Galeotti N. μ Opioid Receptor-Triggered Notch-1 Activation Contributes to Morphine Tolerance: Role of Neuron–Glia Communication. Mol Neurobiol 2020;57:331-45. [DOI: 10.1007/s12035-019-01706-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
144 Jonas KC, Chen S, Virta M, Mora J, Franks S, Huhtaniemi I, Hanyaloglu AC. Temporal reprogramming of calcium signalling via crosstalk of gonadotrophin receptors that associate as functionally asymmetric heteromers. Sci Rep 2018;8:2239. [PMID: 29396488 DOI: 10.1038/s41598-018-20722-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
145 Zamel IA, Palakkott A, Ashraf A, Iratni R, Ayoub MA. Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay. Front Pharmacol 2020;11:1283. [PMID: 32973514 DOI: 10.3389/fphar.2020.01283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
146 Rivera-Oliver M, Moreno E, Álvarez-Bagnarol Y, Ayala-Santiago C, Cruz-Reyes N, Molina-Castro GC, Clemens S, Canela EI, Ferré S, Casadó V, Díaz-Ríos M. Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron. Mol Neurobiol 2019;56:797-811. [PMID: 29797183 DOI: 10.1007/s12035-018-1120-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
147 Kim H, Nam M, Jeong S, Lee H, Oh S, Kim J, Choi N, Seong J. Visualization of differential GPCR crosstalk in DRD1-DRD2 heterodimer upon different dopamine levels. Progress in Neurobiology 2022. [DOI: 10.1016/j.pneurobio.2022.102266] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Plach M, Schäfer T, Borroto-Escuela DO, Weikert D, Gmeiner P, Fuxe K, Friedland K. Differential allosteric modulation within dopamine D2R - neurotensin NTS1R and D2R - serotonin 5-HT2AR receptor complexes gives bias to intracellular calcium signalling. Sci Rep 2019;9:16312. [PMID: 31704949 DOI: 10.1038/s41598-019-52540-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
149 Wu Q, Xu F, Liu L, Char SN, Ding Y, Je BI, Schmelz E, Yang B, Jackson D. The maize heterotrimeric G protein β subunit controls shoot meristem development and immune responses. Proc Natl Acad Sci U S A 2020;117:1799-805. [PMID: 31852823 DOI: 10.1073/pnas.1917577116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
150 Moreno E, Quiroz C, Rea W, Cai NS, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, Ferré S. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area. J Neurosci 2017;37:1176-86. [PMID: 28007761 DOI: 10.1523/JNEUROSCI.2442-16.2016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
151 DiCello JJ, Carbone SE, Saito A, Rajasekhar P, Ceredig RA, Pham V, Valant C, Christopoulos A, Veldhuis NA, Canals M, Massotte D, Poole DP. Mu and Delta Opioid Receptors Are Coexpressed and Functionally Interact in the Enteric Nervous System of the Mouse Colon. Cell Mol Gastroenterol Hepatol 2020;9:465-83. [PMID: 31759144 DOI: 10.1016/j.jcmgh.2019.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
152 Florido A, Moreno E, Canela EI, Andero R. Nk3R blockade has sex-divergent effects on memory in mice. Biol Sex Differ 2022;13:28. [PMID: 35690790 DOI: 10.1186/s13293-022-00437-z] [Reference Citation Analysis]
153 Sleno R, Hébert TE. Shaky ground - The nature of metastable GPCR signalling complexes. Neuropharmacology 2019;152:4-14. [PMID: 30659839 DOI: 10.1016/j.neuropharm.2019.01.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
154 Gallo M, Moreno E, Defaus S, Ortega-Alvaro A, Gonzalez A, Robledo P, Cavaco M, Neves V, Castanho MARB, Casadó V, Pardo L, Maldonado R, Andreu D. Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects. J Med Chem 2021;64:6937-48. [PMID: 33887904 DOI: 10.1021/acs.jmedchem.1c00484] [Reference Citation Analysis]
155 Casadó-Anguera V, Casadó V. Unmasking allosteric binding sites: Novel targets for GPCR drug discovery. Expert Opin Drug Discov 2022. [PMID: 35649692 DOI: 10.1080/17460441.2022.2085684] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Cortés A, Casadó-Anguera V, Moreno E, Casadó V. The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome. Adv Pharmacol 2019;84:37-78. [PMID: 31229177 DOI: 10.1016/bs.apha.2019.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
157 Shoeib AM, Benson LN, Mu S, MacMillan-Crow LA, Prather PL. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death. Int J Mol Sci 2022;23:3049. [PMID: 35328467 DOI: 10.3390/ijms23063049] [Reference Citation Analysis]
158 Bagher AM, Kelly MEM, Denovan-Wright EM. Combining SRET2 and BiFC to Study GPCR Heteromerization and Protein-Protein Interactions. Methods Mol Biol 2019;1947:199-215. [PMID: 30969418 DOI: 10.1007/978-1-4939-9121-1_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
159 Tao YM, Yu C, Wang WS, Hou YY, Xu XJ, Chi ZQ, Ding YQ, Wang YJ, Liu JG. Heteromers of μ opioid and dopamine D1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner. Br J Pharmacol 2017;174:2842-61. [PMID: 28608532 DOI: 10.1111/bph.13908] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
160 Sposini S, Hanyaloglu AC. Evolving View of Membrane Trafficking and Signaling Systems for G Protein-Coupled Receptors. In: Lamaze C, Prior I, editors. Endocytosis and Signaling. Cham: Springer International Publishing; 2018. pp. 273-99. [DOI: 10.1007/978-3-319-96704-2_10] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]